Tom McCord
Chief Executive Officer
Replay available
Ironwood Pharmaceuticals, Inc. (IRWD) Q4 2024 Earnings Call
Ironwood Pharmaceuticals, Inc. (NASDAQ: IRWD) Q4 2024 earnings conference call, held 2025-02-27. Replay captured from the company's public earnings webcast.
Hosted by
Featured presenters
Mike Schatzlein
Chief Medical Officer
Greg Martini
Chief Financial Officer
Chase Knickerbocker
Analyst, Quay Callum
Jason Butler
Analyst, Citizens JMP
Matt Calper
Analyst (on for Festival)
David Amsalem
Analyst, Piper Sandler
Investor webinar replay
Watch the replay and follow the connected company analysis, news, and investor updates for Ironwood Pharmaceuticals, Inc..
Replay transcript excerpt
WEBVTT 00:00:01.972 -- 00:00:05.696 My name is Kathleen and I will be your conference operator today. 00:00:05.696 -- 00:00:11.121 At this time, I would like to welcome everyone to the Ironwood Pharmaceuticals 00:00:11.121 -- 00:00:13.824 fourth quarter 2024 investor 00:00:13.824 -- 00:00:16.387 update conference call. 00:00:16.387 -- 00:00:21.011 All lines have been placed on mute to prevent any background noise. 00:00:21.011 -- 00:00:25.937 After the speaker's remarks, there will be a question and answer session. 00:00:25.937 -- 00:00:31.503 Thank you. I would now like to turn the call over to Greg Martini, Chief Financial Officer, 00:00:31.503 -- 00:00:33.963 please go ahead. 00:00:34.107 -- 00:00:39.054 Good morning, and thanks for joining us for our fourth quarter and full year 2024 investor 00:00:39.054 -- 00:00:43.862 update. Our press release issued this morning can be found on our website. 00:00:43.862 -- 00:00:48.228 Today's call and accompanying slides include forward-looking statements within the meaning 00:00:48.228 -- 00:00:52.395 of the Private Securities Litigation Reform Act of 1995. 00:00:52.395 -- 00:00:56.601 Such statements involve risks and uncertainties that may cause actual results to differ 00:00:56.601 -- 00:01:01.488 materially. A discussion of these statements and risk factors is available on the current 00:01:01.488 -- 00:01:05.655 Safe Harbor Statement slide, as well as under the heading Risk Factors in our annual 00:01:05.655 -- 00:01:10.744 report on Form 10-K for the year ended December 31, 2023, and in 00:01:10.744 -- 00:01:13.148 our subsequent SEC filings. 00:01:13.148 -- 00:01:17.675 All forward-looking statements speak as of the date of this presentation, and we undertake 00:01:17.675 -- 00:01:20.845 no obligation to update such ...